Intomics

Intomics specializes in deriving core biological insights through the analysis and integration of biomedical big data. The company operates in the pharmaceutical industry, focusing on increasing the success rate of drug discovery and development projects. Intomics serves clients by helping them investigate the potential of repositioning marketed drugs into other disease areas, identifying genes and proteins as target candidates, uncovering clinically relevant biomarkers, and deciding on the correct model test platform for optimal drug development results. The business model revolves around providing expert counseling and sophisticated technology to integrate various biomedical datasets, thereby enabling precise patient stratification and enhancing in-house bioinformatic capabilities. Intomics generates revenue through consulting services and technology solutions tailored to the needs of pharmaceutical companies.

Keywords: biomedical big data, drug discovery, pharmaceutical industry, drug repositioning, biomarker discovery, target identification, patient stratification, bioinformatics, consulting services, technology solutions.